Epidemiological screening of severe asthmatics and subsequent allergy diagnostics

• Conditions: J45.0; Predominantly allergic asthma

• Registration Number: DRKS00010432
• Lead Sponsor: ovartis Pharma GmbH

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2016-04-26
• Study Completion: 2017-01-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting stopped after recruiting started
• Sex: All
• Target Recruitment: 815

Inclusion Criteria

1. Minimum age of 7 years

2. Patients who were qualified by a standardized online and call center questionnaire as severe, uncontrolled asthmatics

3. Medical diagnosis of uncontrolled Asthma (GINA step 4 or 5) by the site physician

4. Patient's written informed consent given. For minors IC must be given also by parents/legal representative

Exclusion Criteria

see Inclusion criteria

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Gain of epidemiological data of asthmatics and data collection concerning their immunological status (perennial and seasonal aero-allergens) with an extended ImmunoCAP test.

Secondary Outcome Measures

Name	Time	Method
Development of a standard for testing aero-allergens.